News

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
FAT jabs like Ozempic are set to get the seal of approval from the World Health Organisation (WHO). This would back the use ...
A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...
The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Known for weight loss, Wegovy and Ozempic are now showing promising results against MASH—a serious liver disease with no ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...